BMRA Biomerica, Inc.
Healthcare$2.49+0.00%OpenMarket Cap: $7.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.26
P/S
1.78
EV/EBITDA
-1.70
DCF Value
$-69.60
FCF Yield
-41.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
4.3%
Operating Margin
-123.7%
Net Margin
-96.5%
ROE
-98.1%
ROA
-85.6%
ROIC
-152.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $987.0K | -4.5% | $-1.3M | $-1.3M | $— | — |
| Q2 null | $1.2M | 4.2% | $-1.4M | $-1.3M | $— | — |
| Q1 null | $1.4M | 30.7% | $-1.1M | $2.0K | $— | — |
| Q4 null | $749.0K | -32.6% | $-1.6M | $-1.5M | $— | — |
| FY null | $5.3M | 9.4% | $-5.1M | $-5.0M | $— | — |
| Q3 null | $1.1M | 1.7% | $-1.2M | $-1.2M | $— | — |
| Q2 null | $1.6M | 26.7% | $-993.0K | $-950.0K | $— | — |
| Q1 null | $1.8M | 16.0% | $-1.4M | $-1.3M | $— | — |
| Q4 null | $1.1M | 1.8% | $-1.5M | $-1.4M | $— | — |
| FY null | $5.4M | 11.3% | $-6.4M | $-6.0M | $— | — |
| Q3 2024 | $1.0M | -14.7% | $-2.0M | $-1.9M | $-0.11 | — |
| Q2 2024 | $1.6M | 20.7% | $-1.6M | $-1.5M | $-0.09 | — |